Matthew Ocko's Net Worth

$0

Estimate Recalculated Nov 1, 2024 06:41AM EST

Who is Matthew Ocko?

Matthew Ocko does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RECURSION PHARMACEUTICALS, INC., Embark Technology, Inc., AbCellera Biologics Inc., Rocket Lab USA, Inc., and Zymergen Inc..

SEC CIK

Matthew Ocko's CIK is 0001836089

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RECURSION PHARMACEUTICALS, INC. (RXRX) Snapshot price: $5.95

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
13.62M
—
—
13.62M
Apr 20
Form 3
—
0
—
—
0
No matching records found

Embark Technology, Inc. No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.31%
10K
$9.64
$96,388.00
3.21M
Aug 30
Form 4
+0.31%
10K
$11.64
$116,383.00
3.2M
Aug 18
Form 4
+3.97%
122K
$0.84
$102,150.60
3.19M
Aug 16
Form 3
—
0
—
—
0
No matching records found

AbCellera Biologics Inc. (ABCL) Snapshot price: $2.42

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-16.92%
-4.93M
—
—
24.18M
Jun 18
Form 4
∞
29.11M
—
—
29.11M
Dec 15
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Rocket Lab USA, Inc. (RKLB) Snapshot price: $5.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Zymergen Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-7.37M
—
—
0
Oct 19
Form 4
+137.14%
7.37M
—
—
12.74M
Apr 26
Form 3
—
0
—
—
0
No matching records found